European Urology - Extended Duration of Efficacy of Vardenafil When Taken 8 Hours Before Intercourse: A Randomized, Double-Blind, Placebo-Controlled Study
Monday, 13 November 2006 Volume 50, Issue 5, Pages 1086-1095 (November 2006) 1. Introduction - It has been estimated that >150 million men worldwide experience erectile dysfunction (ED) and that its prevalence is likely to rise with the ageing population [1], [2].
read more
|
European Urology - Rationale for Androgens and Erectile Dysfunction in 2006
Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 898-900 (November 2006) Article Outline: Erectile function (EF) is a critical and complex neurovascular process mediated by several biochemical and physiologic factors.
read more
|
European Urology - Sulcus Nervi Dorsalis Penis/Clitoridis: Anatomic Structure and Clinical Significance
Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 1079-1085 (November 2006) Abstract - Objectives: The aim of this study was to correlate the anatomic and clinical significance of the prepubic course of dorsal nerve of penis and its groove on the pubic bone from the perspective of the surgeon.
read more
|
European Urology - Vardenafil Duration of Action
Wednesday, 25 October 2006 Volume 50, Issue 5, Pages 901-902 (November 2006) Article Outline: The time we spend with a patient explaining how to use a phosphodiesterase type 5 inhibitor (PDE5-I) and the quality of the information we provide are recognised as important factors that contribute to the success of the treatment.
read more
|
Most Medicare Prescription Drug Plans will Drop Coverage for Erectile Dysfunction Medications
Tuesday, 24 October 2006 UroToday.com(Press Release) - Most Medicare prescription drug plans in 2007 will not cover erectile dysfunction treatments such as Viagra, Cialis and Levitra, the St. Louis Post-Dispatch reports.
read more
|
European Urology - Association between Erectile Dysfunction and Coronary Artery Disease: Matching the Right Target with the Right Test in the Right Patient
Monday, 23 October 2006 Volume 50, Issue 4, Pages 721-731 (October 2006) 1. Introduction Erectile dysfunction (ED) is defined as the inability to reach or maintain erection sufficient for satisfactory sexual performance. Evidence is accumulating in favour of ED as a vascular disorder in the majority of patients.
read more
|
UroToday Reports:Erectile Dysfunction Predicts Extension of Coronary Artery Disease by Angiography in Acute Coronary Syndromes. The Dead Goose Study.
Thursday, 19 October 2006 BERKELEY, CA (UroToday.com) - The authors of this study point out that erectile dysfunction (ED) and coronary artery disease (CAD) frequently coexist.
read more
|
Results of the First Human Trial for Gene Transfer Therapy for the Treatment of Erectile Dysfunction
Tuesday, 17 October 2006 ATLANTA, GA (UroToday.com) - AUA 2006 - Abstract 686: Gene therapy for erectile dysfunction, the gene transfer of relevant molecules involved in the regulation of penile erection, has emerged from just an imaginable possibility to an exciting reality.
read more
|
European Urology - Erectile Dysfunction and Vascular Risk: Let's Get It Right
Monday, 02 October 2006 Volume 50, Issue 4, Pages 660-661 (October 2006) The current consensus is that erectile dysfunction (ED) and vascular disease often coexist and that endothelial dysfunction is the common denominator [1].
read more
|
European Urology - Sexual Function Before and After Radical Retropubic Prostatectomy: A Systematic Review of Prognostic Indicators for a Successful Outcome
Monday, 02 October 2006 Volume 50, Issue 4, Pages 711-720 (October 2006) Abstract - Objectives: Erectile dysfunction is common after surgery for prostate cancer. Potency rates after radical retropubic prostatectomy (RRP) vary widely among different studies.
read more
|
European Urology - The Metabolic Syndrome and Erectile Dysfunction: Multiple Vascular Risk Factors and Hypogonadism
Tuesday, 26 September 2006 Volume 50, Issue 3, Pages 426-427 (September 2006) In this issue Corona and colleagues conclude that erectile dysfunction (ED) is more severe in patients with the metabolic syndrome and associated with an increased incidence of hypogonadism [1]. The findings have important lifestyle, prevention, and therapeutic implications.
read more
|
European Urology - Testosterone Deficiency Syndrome (TDS) Needs to be Named Appropriately – The Importance of Accurate Terminology
Tuesday, 26 September 2006 Volume 50, Issue 3, Pages 407-409 (September 2006) The decline in androgen production in association with increasing age has been recognized and documented for decades [1]. The prevalence and incidence of the condition has been estimated [2] and its treatment is becoming established [3]. Controversy however still exists on the clinical relevance of diminishing plasma testosterone (T) levels [4].
read more
|
Association between Sexual Motivation and Patterns of Erectile Dysfunction
Monday, 25 September 2006 BERKELEY, CA (UroToday.com) - The prevalence and outcome of ED therapy among long-term prostate cancer (CaP) survivors is reported by Dr. Miller and colleagues at the University of Michigan in the July 2006 issue of Urology.
read more
|
European Urology - Serotonin and Premature Ejaculation: From Physiology to Patient Management
Sunday, 24 September 2006
Volume 50, Issue 3, Pages 454-466 (September 2006)
Abstract -
Introduction:
Premature ejaculation (PE), whose pathophysiology is still not clearly identified, is the most common male sexual dysfunction, yet it remains underdiagnosed and undertreated. The aims of this paper are to provide a scientific and pharmacologic rationale, and to discuss to what extent selective serotonin reuptake inhibitors (SSRIs) can help patients with PE.
read more
|
European Urology - Psychobiologic Correlates of the Metabolic Syndrome and Associated Sexual Dysfunction
Sunday, 24 September 2006 Volume 50, Issue 3, Pages 595-604 (September 2006) 1. Introduction: A worldwide epidemic increase in obesity has occurred in recent decades and will steadily increase in the near future, due to substantial lifestyle changes [1].
read more
|